ICPT PDUFA for NASH is 3/26/20 (with priority review): https://www.globenewswire.com/news-release/2019/11/25/1951936/0/en/FDA-Accepts-Intercept-s-NDA-for-OCA-for-the-Treatment-of-Liver-Fibrosis-Due-to-NASH-and-Grants-Priority-Review.html